摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole | 854020-40-9

中文名称
——
中文别名
——
英文名称
5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole
英文别名
(2R,3R,4S,5R)-2-[5-amino-4-(1H-imidazol-2-yl)pyrazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole化学式
CAS
854020-40-9
化学式
C11H15N5O4
mdl
——
分子量
281.271
InChiKey
GJCKCHMTKULCEV-KCGFPETGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.9
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    142
  • 氢给体数:
    5
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole溶剂黄146 、 sodium nitrite 作用下, 反应 0.5h, 以83%的产率得到7-(β-D-ribofuranosyl)-imidazo[1,2-c]-7H-pyrazolo[4,3-e][1,2,3]triazine
    参考文献:
    名称:
    1,N6-Etheno-7-deaza-2,8-diazaadenosine: syntheses, properties and conversion to 7-deaza-2,8-diazaadenosine
    摘要:
    1,N6-Etheno-7-去氮-2,8-二氮腺苷(4)以64%的总产率从8-氮杂-7-去氮腺苷(6)合成。原料6是通过8-氮杂-7-去氮腺嘌呤(7)与1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖(8)直接糖基化获得的(NO2 CH3, BF3·Et2O; 产率77%)。化合物4被转化为7-去氮-2,8-二氮腺苷(5)。化合物4的荧光显示在531 nm处有最大发射峰(磷酸盐缓冲液;pH 7.0),与1,N6-乙烯基-2-氮杂腺苷(3a)(495 nm)相比,发生了向红端偏移。在固态和溶液中进行了构象分析。
    DOI:
    10.1039/b418849g
  • 作为产物:
    参考文献:
    名称:
    1,N6-Etheno-7-deaza-2,8-diazaadenosine: syntheses, properties and conversion to 7-deaza-2,8-diazaadenosine
    摘要:
    1,N6-Etheno-7-去氮-2,8-二氮腺苷(4)以64%的总产率从8-氮杂-7-去氮腺苷(6)合成。原料6是通过8-氮杂-7-去氮腺嘌呤(7)与1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖(8)直接糖基化获得的(NO2 CH3, BF3·Et2O; 产率77%)。化合物4被转化为7-去氮-2,8-二氮腺苷(5)。化合物4的荧光显示在531 nm处有最大发射峰(磷酸盐缓冲液;pH 7.0),与1,N6-乙烯基-2-氮杂腺苷(3a)(495 nm)相比,发生了向红端偏移。在固态和溶液中进行了构象分析。
    DOI:
    10.1039/b418849g
点击查看最新优质反应信息

文献信息

  • 7-SUBSTITUTED 8-AZA-7-DEAZAPURINES AND 2,8-DIAZA-7-DEAZA-PURINES: SYNTHESIS OF NUCLEOSIDES AND OLIGONUCLEOTIDES
    作者:Wenqing Lin、Kuiying Xu、Frank Seela
    DOI:10.1081/ncn-200059218
    日期:2005.4.1
    7-Substituted 8-aza-7-deazaadenosines la-e were synthesized by Sonogashira cross coupling from the corresponding 7-iodo nucleoside in 36- 79% yields. Starting from 7-bromo (or 7-iodo)-8-aza- 7-deazaadenine, 2a,b were obtained by acid-catalyzed glycosylation followed by deprotection in 53 and 35% yields, respectively. Compounds 2b was applied to cross coupling reaction to give 2c-d in 34-95% yield. Compounds 2a and 4b were further transformed to the phosphoramidites 5 and 6b in 9 and 49% overall yields, which were incorporated into oligonucleotides.
  • 1,N6-Etheno-7-deaza-2,8-diazaadenosine: syntheses, properties and conversion to 7-deaza-2,8-diazaadenosine
    作者:Wenqing Lin、Hong Li、Xin Ming、Frank Seela
    DOI:10.1039/b418849g
    日期:——
    1,N6-Etheno-7-deaza-2,8-diazaadenosine (4) was synthesized from 8-aza-7-deazaadenosine (6) in 64% overall yield. The starting material 6 was obtained by the direct glycosylation of 8-aza-7-deazaadenine (7) with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose (8) (NO2 CH3, BF3·Et2O; 77% yield). Compound 4 was transformed into 7-deaza-2,8-diazaadenosine (5). The fluorescence of compound 4 shows an emission maximum at 531 nm (phosphate buffer; pH 7.0), which is bathochromically shifted compared to 1,N6-etheno-2-azaadenosine (3a) (495 nm). A conformational analysis was performed in the solid state and in solution.
    1,N6-Etheno-7-去氮-2,8-二氮腺苷(4)以64%的总产率从8-氮杂-7-去氮腺苷(6)合成。原料6是通过8-氮杂-7-去氮腺嘌呤(7)与1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖(8)直接糖基化获得的(NO2 CH3, BF3·Et2O; 产率77%)。化合物4被转化为7-去氮-2,8-二氮腺苷(5)。化合物4的荧光显示在531 nm处有最大发射峰(磷酸盐缓冲液;pH 7.0),与1,N6-乙烯基-2-氮杂腺苷(3a)(495 nm)相比,发生了向红端偏移。在固态和溶液中进行了构象分析。
查看更多

同类化合物

5-甲基-4-硝基-1-(β-D-呋喃核糖基)-1H-吡唑-3-甲酰胺 1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]吡唑-3,4-二甲酰胺 1-β-D-ribofuranosylpyrazole 4-iodo-3-(3'-methyl-1',2',4'-oxadiazolyl)-1-β-D-ribofuranosylpyrazole 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxamide 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole 4-phenylethynyl-1-β-D-ribofuranosylpyrazole-3-carboxamide 3,5-dimethyl-1-(α-D-arabinofuranosyl)pyrazole methyl 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxylate ethyl 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-ethoxycarbonylthiocarbamoyl)amino>pyrazole-4-carboxylate methyl 3-[5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-1H-pirazol-4-yl]-4,4,4-trifluoro-3-hydroxybutanoate 5-Amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-4-carboximidamide 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-(dimethylaminodiazenyl)pyrazole-4-carboxamide 3-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 5-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-thiocarboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 2-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3-carboxamide 1H-Pyrazole-3-carboxamide, 1-beta-D-ribofuranosyl- 1H-Pyrazolo-3-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1H-Pyrazole-5-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3,5-dicarboxamide 2-[5-amino-4-(1H-1,2,4-triazol-5-yl)pyrazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol Ethyl 2-[3,4-diacetyloxy-5-(acetyloxymethyl)oxolan-2-yl]-4-nitropyrazole-3-carboxylate 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-3-methyl-5-(methylthio)pyrazole methyl 4-phenylethynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-β-D-arabinofuranosyl)pyrazole methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 5-amino-1-(2',3'O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-benzoyl-S-methylisothiocarbamoyl)amino>pyrazole-4-carboxamide 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide methyl 4-iodo-1-β-D-ribofuranosyl-pyrazole-3-carboxylate 5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxaldehyde 1-deoxy-1-N-pyrazolyl-2,3-O-isopropylidene-D-ribofuranose 1-(3,5-dimethyl-pyrazol-1-yl)-O2,O3-isopropylidene-D-1,4-anhydro-ribitol methyl 3-cyanomethyl-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)pyrazole-4-carboxylate 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide methyl 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxylate 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-5-(chloromethyl)pyrazole-3-carboxamide 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3-(chloromethyl)pyrazole-5-carboxamide 5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole 4-iodo-1-β-D-ribofuranosylpyrazole-3-carboxamide